Ginger Hart
Acute Care · Little Rock, ARNPI 1750871570
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $5,709 of the $8,685 with a category attached, or 65.7%. 28 manufacturers reported payments, led by Medtronic at 54.7% of the total. Among acute care clinicians in AR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 303 payments — averaging $28.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$5K
- Novartis$1K
- Pfizer$629
- Johnson & Johnson$305
- Alnylam Pharmaceuticals Inc.$290
- AstraZeneca$268
- plus $1K from 22 others
What the payments were for
- Travel & lodging$2,96134%
- Food & beverage$5,70966%
- Education$140%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 53 | $4,753 |
| Novartis | 79 | $1,031 |
| Pfizer | 43 | $629 |
| Johnson & Johnson | 21 | $305 |
| Alnylam Pharmaceuticals Inc. | 16 | $290 |
| AstraZeneca | 16 | $268 |
| Boston Scientific | 7 | $207 |
| Boehringer Ingelheim | 11 | $179 |
| Sanofi-aventis U.S. LLC | 8 | $151 |
| Merck | 9 | $149 |
| Baxter Healthcare | 6 | $109 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $84 |
| Philips North America LLC | 4 | $59 |
| E.r. Squibb & Sons, L.L.C. | 4 | $56 |
| Bridgebio Pharma, Inc. | 3 | $54 |
| Atricure, Inc. | 2 | $51 |
| Abbott | 2 | $50 |
| Kiniksa Pharmaceuticals International, PLC | 2 | $36 |
| Irhythm Technologies, Inc. | 2 | $34 |
| Lexicon Pharmaceuticals, Inc. | 2 | $33 |
| Novo Nordisk | 2 | $31 |
| Abiomed | 1 | $31 |
| Amarin Pharma, Inc. | 1 | $22 |
| Bayer | 1 | $18 |
| Scpharmaceuticals Inc. | 1 | $17 |
| United Therapeutics Corporation | 1 | $15 |
| Amgen | 1 | $12 |
| Cvrx, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LINQ II$1,130
- SelectSecure$787
- AURORA EV-ICD MRI SURESCAN$267
- Micra$141
- MyCareLink$114
- LEQVIO$103
How this compares
$8,685 in reported general payments places this provider in the 95th percentile of 321 acute care providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 149 | $106,300 |
| XareltoRivaroxaban | 89 | $67,621 |
| EntrestoSacubitril/Valsartan | 72 | $48,000 |
| MultaqDronedarone Hcl | 12 | $16,410 |
| JardianceEmpagliflozin | 15 | $15,501 |
| FarxigaDapagliflozin Propanediol | 16 | $15,161 |
| Dofetilide | 32 | $5,170 |
| Metoprolol Succinate | 199 | $2,976 |
| Flecainide Acetate | 75 | $2,908 |
| Propafenone Hcl ErPropafenone Hcl | 14 | $2,256 |
| Propafenone Hcl | 50 | $1,384 |
| Digoxin | 65 | $1,224 |
| SotalolSotalol Hcl | 75 | $1,007 |
| Metoprolol Tartrate | 199 | $976 |
| Carvedilol | 167 | $966 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $629 | $106,300149 claims |
| Johnson & JohnsonXarelto | $305 | $67,62189 claims |
| NovartisEntresto | $1,031 | $48,00072 claims |
| Sanofi-aventis U.S. LLCMultaq | $151 | $16,41012 claims |
| Boehringer IngelheimJardiance | $179 | $15,50115 claims |
| AstraZenecaFarxiga | $268 | $15,16116 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 321 acute care providers in Arkansas.
Other acute care in Little Rock
- Jill AveryLittle Rock$117K
- Lynn FrazierLittle Rock$106K
- Beverly BaxterLittle Rock$95K
- Diane GlendinningLittle Rock$26K
- Beth CrowderLittle Rock$25K
- Carmen Paniagua TorresLittle Rock$21K
- Shana KloskeLittle Rock$14K
- Debra BrentLittle Rock$9K
- Holly TrottaLittle Rock$7K
- Katelyn LomaxLittle Rock$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.